Buckling Up for Omicron
Although widespread vaccination against COVID-19 remains the top priority, the emergence of the Omicron variant indicates that additional lines of defense are needed. The most promising complement by far lies in new-generation monoclonal antibody treatments.
BOSTON β As yet another new SARS-CoV-2 variant emerges and begins to spread β one with a worryingly large set of mutations that may make the virus more capable of evading our immune defenses β we are all being forced to reassess the strategies we have come to rely on for protection.